Dr. Goff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1301 Medical Center Dr
Nashville, TN 37232Phone+1 615-936-8422Fax+1 615-322-6004- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2001 - 2004
- The University of Texas Health Science Center at San AntonioClass of 2001
Certifications & Licensure
- TN State Medical License 2004 - 2025
- AL State Medical License 2020 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors Start of enrollment: 2007 Aug 01
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Start of enrollment: 2016 Feb 19
- A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer Start of enrollment: 2016 May 19
Publications & Presentations
PubMed
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Eliza Beal, Richard S Finn, Terence P Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T Hoang, Renuka Iyer, Ishm...> ;Journal of Clinical Oncology. 2024 Mar 19
- Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.Margaret Wheless, Rajiv Agarwal, Laura Goff, Natalie Lockney, Chandrasekhar Padmanabhan, Thatcher Heumann> ;Current Treatment Options in Oncology. 2024 Jan 1
- NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.Michael Cecchini, James M Cleary, Yu Shyr, Joseph Chao, Nataliya Uboha, May Cho, Anthony Shields, Shubham Pant, Laura Goff, Kristen Spencer, Edward Kim, Stacey Stein, ...> ;British Journal of Cancer. 2024 Feb 1
- Join now to see all
Lectures
- New Multidisciplinary Approaches to Diagnosis and Palliation in Hepato-Pancreato-Biliary TumorsASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Sequencing Systemic Therapy in Hepatocellular Carcinoma: Immune Checkpoint Inhibitor or Tyrosine...ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
Press Mentions
- NALIRIFOX: A New Reference Standard for Metastatic Pancreatic AdenocarcinomaJanuary 23rd, 2023
- Renewed Interest in Radiation for Hepatocellular Carcinoma?January 23rd, 2023
- New First-Line Standard for Metastatic Pancreatic CancerJanuary 22nd, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Vanderbilt University Medical CenterNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: